Ipilimumab/nivolumab/pembrolizumab

Various toxicities: 3 case reports

    This is a preview of subscription content, access via your institution.

    Reference

    1. Jiwa N, et al. A case series of hereditary neuromuscular disorders in patients with neuromuscular immune-related adverse events secondary to immune checkpoint inhibitors. Muscle and Nerve 60 (Suppl. 1): S43, Sep 2019. Available from: URL: https://onlinelibrary.wiley.com/toc/10974598/2019/60/S1 [abstract]

    Download references

    Rights and permissions

    Reprints and Permissions

    About this article

    Verify currency and authenticity via CrossMark

    Cite this article

    Ipilimumab/nivolumab/pembrolizumab. Reactions Weekly 1840, 228 (2021). https://doi.org/10.1007/s40278-021-90371-z

    Download citation